摘要
Anthony BENEDETTO 医师
皮肤科医师
How to choose one toxin brand over another?
Objectives: To understand the differences between the various proprietary Botulinum toxin As (BTX-As) available in the USA.
To identify and appreciate the subtle differences between the available BTX-As that will influence how treatment injections should be performed.
To choose the proper BTX-A product in order to create the most beneficial results for individual patients.
Introduction: OnabotulinumtoxinA, brand named BOTOX, was approved for cosmetic purposes in 2002. Since then, there have been additional BTX-As developed, distributed worldwide and approved for cosmetic use in the USA by the FDA. All the available BTX-A products contain the same neurotoxin molecule, but because of different propriety accessory proteins and stabilizing molecules, the different brand named products vary in subtle ways which influence the manner in which they should be injected.
Materials / method: The BTX-As currently available in the USA will be identified and categorized according to their individual proprietary differences. These subtle variations in the BTX-A products will determine how they can be optimally utilized when injecting them for cosmetic purposes.
Results: The different BTX-A products will be differentiated by how long their results last, how easily they diffuse within the skin and muscle, how quickly the product takes effect and how reliably reproducible are their results.
Conclusion: Depending on whether one is injecting BTX-A on-label for cosmetic or therapeutic purposes or off-label for cosmetic or therapeutic purposes, selecting the appropriate BTX-A is important. All the different named BTX-As contain the same neurotoxin molecule, but because of different propriety accessory proteins and stabilizing molecules, these BTX-A products vary in subtle ways which influence the manner in which they should be injected. These differences will be identified and the injection techniques emphasized.
披露 - Anthony BENEDETTO
> 您是否获得了任何资金来支持您关于这个主题的研究?
不是
> 您在这项研究工作中是否获得过任何酬金、报酬或其他形式的补偿?
不是
> 您是否与任何可能与您研究中涉及的药物、材料或器械存在激烈竞争的实体有任何财务关系?
不是
> 您是否拥有或已申请过与您研究中所讨论的仪器、药物或材料相关的任何专利?
不是
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。
Published on 2025年 4月 1日 - Recorded during IMCAS World Congress 2025